Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
In clinical trials for Zepbound (Tirzepatide) , hair loss was reported in approximately 4% to 5% of individuals taking the medication, compared with 1% in the placebo group
Semaglutide (GLP-1) was originally developed to help people with type 2 diabetes manage their blood sugar levels
People who might benefit the most from switching from semaglutide to tirzepatide include those who: Havent lost as much weight as they hoped to on semaglutide, or have run into a weight loss plateau Havent reached their target HbA1c levels on semaglutide, or are hoping for further reductions Have another health condition that only tirzepatide is FDA-approved to treat, such as obstructive sleep apnea If semaglutide hasnt been working well for you, it might be worth switching to tirzepatide
However, he says there often is not a big change in price between a maximum tolerated dose of an injectable medication and a maintenance dose
The pivotal data come from randomized, placebo-controlled Phase 3 trials in the STEP program
US$ 20.77
US$ 27.01
US$ 21.45
US$ 23.19
US$ 26.36
US$ 23.55
,aspect=ignore)
US$ 20.07
